Next Generation Molecular Assay Market Market - Top Companies and Manufacturers

In the News

• Bio-Rad laboratories announced its partnership with Allegheny Health Network Cancer Institute in April 2024 to advance the molecular residue disease monitoring of solid tumor cancers with Bio-Rad’s Droplet Digital™ PCR (ddPCR™).
• US Health offered BRAF Gene Mutation Assay and Microsatellite Instability Assay, two in-house molecular oncology tests which means faster results and faster treatment. These tests are capable of detecting the mutation from tumor tissue and cytology specimens in cancer patients.
• CMIC has joined LC Scrum AP screening project on non-small cell lung cancer, being run by National Cancer Center Hospital East and Precision Medicine Asia (PREMIA). CMIC is a leading innovator in the industry and, became the first contract research organization to join this project.
• Novogene made a big announcement for providing flexibility to researchers along with enhancing research strategies. At the 44th Annual Meeting of the Molecular Biological Society of Japan (MSBJ), Novogene, well known for its genomic services announced the launch of single cell sequencing on-site services for Japan-specific customers.